NAFLD - sounding the alarm on a silent epidemic

Jeffrey V Lazarus^{1

2}, Massimo Colombo^{3

4}, Helena Cortez-Pinto⁵, Terry T-K Huang⁶, Veronica Miller⁷, Michael Ninburg^{8

9}, Jörn M Schattenberg¹⁰, Lynn Seim¹¹, Vincent W S Wong¹², Shira Zelber-Sagi^{13

14}

Affiliations

¹ Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain. jeffrey.lazarus@isglobal.org.
² EASL International Liver Foundation, Geneva, Switzerland. jeffrey.lazarus@isglobal.org.
³ EASL International Liver Foundation, Geneva, Switzerland.
⁴ Department of Medicine, Humanitas Hospital, Rozzano, Italy.
⁵ Clínica Universitária de Gastrenterologia, Laboratório de Nutrição, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
⁶ Center for Systems and Community Design and NYU-CUNY Prevention Research Center, Graduate School of Public Health and Health Policy, City University of New York, New York, NY, USA.
⁷ University of California Berkeley, School of Public Health, Forum for Collaborative Research, Washington DC, DC, USA.
⁸ Hepatitis Education Project, Seattle, WA, USA.
⁹ World Hepatitis Alliance, London, UK.
¹⁰ Metabolic Liver Research Program, I. Department of Medicine, University Medical Center, Mainz, Germany.
¹¹ American Liver Foundation, New York, NY, USA.
¹² Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
¹³ School of Public Health, University of Haifa, Haifa, Israel.
¹⁴ Department of Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel.

Jeffrey V Lazarus et al. Nat Rev Gastroenterol Hepatol. 2020 Jul.

. 2020 Jul;17(7):377-379.

doi: 10.1038/s41575-020-0315-7.

¹ Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain. jeffrey.lazarus@isglobal.org.
² EASL International Liver Foundation, Geneva, Switzerland. jeffrey.lazarus@isglobal.org.
³ EASL International Liver Foundation, Geneva, Switzerland.
⁴ Department of Medicine, Humanitas Hospital, Rozzano, Italy.
⁵ Clínica Universitária de Gastrenterologia, Laboratório de Nutrição, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
⁶ Center for Systems and Community Design and NYU-CUNY Prevention Research Center, Graduate School of Public Health and Health Policy, City University of New York, New York, NY, USA.
⁷ University of California Berkeley, School of Public Health, Forum for Collaborative Research, Washington DC, DC, USA.
⁸ Hepatitis Education Project, Seattle, WA, USA.
⁹ World Hepatitis Alliance, London, UK.
¹⁰ Metabolic Liver Research Program, I. Department of Medicine, University Medical Center, Mainz, Germany.
¹¹ American Liver Foundation, New York, NY, USA.
¹² Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
¹³ School of Public Health, University of Haifa, Haifa, Israel.
¹⁴ Department of Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel.

No abstract available

References

1. Zhang, C., Shi, L. & Wang, F. S. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol. Hepatol. https://doi.org/10.1016/s2468-1253(20)30057-1 (2020). - DOI - PubMed - PMC
1. Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73–84 (2016). - DOI
1. Estes, C. et al. Modelling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J. Hepatol. 69, 896–904 (2018). - DOI
1. Schattenberg, J. et al. The economic burden of patients diagnosed with non-alcoholic steatohepatitis in France, Germany, Italy, Spain and the United Kingdom in 2018 (Poster) https://www.postersessiononline.eu/173580348_eu/congresos/NAFLD2019/aula... (2019).
1. Cotter, T. G. & Rinella, M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology https://doi.org/10.1053/j.gastro.2020.01.052 (2020). - DOI - PubMed